Family Physicians' Barriers and Facilitators in Incorporating Medication Abortion

被引:7
|
作者
Razon, Na'amah [1 ]
Wulf, Sarah [2 ]
Perez, Citlali [2 ]
McNeil, Sarah [3 ,4 ]
Maldonado, Lisa [5 ]
Fields, Alison Byrne [6 ]
Holt, Kelsey [2 ]
Fox, Edith [2 ]
Silverstein, Ilana [2 ]
Dehlendorf, Christine [2 ]
机构
[1] Univ Calif Davis, Dept Family & Community Med, 4860 Y St,Suite 2300, Sacramento, CA 95817 USA
[2] Univ Calif San Francisco, Dept Family & Community Med, Person Ctr Reprod Hlth Program, San Francisco, CA USA
[3] Costa Reg Med Ctr, Dept Family Med, Martinez, CA USA
[4] Costa Reg Med Ctr, Dept Ob Gyn, Martinez, CA USA
[5] Reprod Hlth Access Project, New York, NY USA
[6] Aggregate, Seattle, WA USA
关键词
Contraception; Drug-Induced Abortion; Family Medicine; Family Physicians; Health Policy; Health Services Accessibility; Mifepristone; Patient-Centered Care; Primary Health Care; Qualitative Research; Reproductive Health; Scope of Practice; SERVICE AVAILABILITY; UNITED-STATES; MANAGEMENT;
D O I
10.3122/jabfm.2022.03.210266
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: Medication abortion (MAB) provision by family physicians has the potential to expand abortion access. However, there are documented individual and structural barriers to provision. This study investigates how family physicians in the United States (US) navigate the barriers impeding abortion provision in primary care. Methods: We conducted a qualitative study on the experiences of US family physicians with MAB in primary care. We recruited participants at national conferences and via professional networks. This analysis focuses on the experiences of the subset of participants who expressed interest in providing MAB. Results: Forty-eight participants met inclusion criteria, with representation from all 4 regions of the US. Participants had diverse experiences related to abortion provision, training, and the environment in which they practice, with a third of participants working in states with hostile abortion policies. We categorized participants into 3 groups: (1) doctors who did not receive training and do not provide abortions (n = 11), (2) doctors who received training but do not provide abortions (n = 20), and (3) doctors who received training and currently provide abortions (n = 17). We found that training, administrative and community support, and internal motivation to overcome barriers help family physicians integrate MAB in primary care practices. Federal and state laws, absence of training, stigma around abortion provision, inaccurate or limited knowledge of institutional barriers, and administrative resistance all contributed to doctors excluding abortion provision from their scope of practice. Conclusion: Improving medication abortion provision by family physicians requires addressing the individual and system barriers family physicians encounter so they receive the education, training, and support to successfully integrate abortion care into clinical practice.
引用
收藏
页码:579 / 587
页数:9
相关论文
共 50 条
  • [41] Willing but unable: Physicians' referral knowledge as barriers to abortion care
    Anderson, Elizabeth M.
    Cowan, Sarah K.
    Higgins, Jenny A.
    Schmuhl, Nicholas B.
    Wautlet, Cynthie K.
    [J]. SSM-POPULATION HEALTH, 2022, 17
  • [42] A Study of Barriers and Facilitators of Clinical Practice Guidelines Implementation among Physicians
    Alnaim, Lamya
    Almaz, Saja
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 79 (06) : 923 - 929
  • [43] Barriers and facilitators perceived by physicians when using prediction models in practice
    Kappen, Teus H.
    van Loon, Kim
    Kappen, Martinus A. M.
    van Wolfswinkel, Leo
    Vergouwe, Yvonne
    van Klei, Wilton A.
    Moons, Karel G. M.
    Kalkman, Cor J.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2016, 70 : 136 - 145
  • [44] BARRIERS AND SUPPORTS TO MEDICATION ABORTION PROVISION BY ADOLESCENT MEDICINE PROVIDERS
    Coles, M.
    Makino, K.
    Phelps, R.
    [J]. CONTRACEPTION, 2011, 84 (03) : 315 - 316
  • [45] Barriers to medication abortion among Massachusetts public university students
    Baker, Carrie N.
    Mathis, Julia
    [J]. CONTRACEPTION, 2022, 109 : 32 - 36
  • [46] Barriers and facilitators of medication adherence in hypertensive African Americans: A qualitative study
    Ogedegbe, G
    Harrison, M
    Robbins, L
    Mancuso, CA
    Allegrante, JP
    [J]. ETHNICITY & DISEASE, 2004, 14 (01) : 3 - 12
  • [47] Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence
    Chong, Chia Chee
    Redzuan, Adyani Md
    Sathar, Jameela
    Makmor-Bakry, Mohd
    [J]. JOURNAL OF PATIENT EXPERIENCE, 2021, 8
  • [48] Barriers and facilitators to medication adherence in a southern minority population with HIV disease
    Konkle-Parker, Deborah J.
    Erlen, Judith A.
    Dubbert, Patricia M.
    [J]. JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2008, 19 (02): : 98 - 104
  • [49] Barriers and facilitators to osteoporosis medication adherence: Patient perceptions and strategies.
    Papaioannou, A
    Pathak, A
    Nair, K
    Burns, S
    Lau, E
    Dolovich, L
    Sawka, A
    Kennedy, C
    Adachi, JD
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S405 - S406
  • [50] MEDICATION ADHERENCE IN CHRONIC CONDITIONS: A SCOPING REVIEW OF BARRIERS, FACILITATORS AND INTERVENTIONS
    Konstantinou, Pinelopi
    Kassianos, Angelos P.
    Georgiou, Giorgos
    Panayides, Andreas
    Papageorgiou, Alexia
    Almas, Ioannis
    Wozniak, Greta E.
    Karekla, Maria
    [J]. ANNALS OF BEHAVIORAL MEDICINE, 2021, 55 : S307 - S307